An economic evaluation of the war on cancer
Author
Abstract
Suggested Citation
Download full text from publisher
As the access to this document is restricted, you may want to look for a different version below or search for a different version of it.
Other versions of this item:
- Eric C. Sun & Anupam B. Jena & Darius N. Lakdawalla & Carolina M. Reyes & Tomas J. Philipson & Dana P. Goldman, 2009. "An Economic Evaluation of the War on Cancer," NBER Working Papers 15574, National Bureau of Economic Research, Inc.
References listed on IDEAS
- Frank R. Lichtenberg, 2004.
"The expanding pharmaceutical arsenal in the war on cancer,"
2004 Meeting Papers
204, Society for Economic Dynamics.
- Frank R. Lichtenberg, 2004. "The Expanding Pharmaceutical Arsenal in the War on Cancer," NBER Working Papers 10328, National Bureau of Economic Research, Inc.
- Philipson Tomas J & Jena Anupam B, 2006.
"Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs,"
Forum for Health Economics & Policy, De Gruyter, vol. 9(2), pages 1-33, January.
- Tomas J. Philipson & Anupam B. Jena, 2005. "Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs," NBER Working Papers 11810, National Bureau of Economic Research, Inc.
- Joseph E. Aldy & W. Kip Viscusi, 2007.
"Age Differences in the Value of Statistical Life: Revealed Preference Evidence,"
Review of Environmental Economics and Policy, Association of Environmental and Resource Economists, vol. 1(2), pages 241-260, Summer.
- Aldy, Joseph E. & Viscusi, W. Kip, 2007. "Age Differences in the Value of Statistical Life: Revealed Preference Evidence," RFF Working Paper Series dp-07-05, Resources for the Future.
- Oaxaca, Ronald, 1973.
"Male-Female Wage Differentials in Urban Labor Markets,"
International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 14(3), pages 693-709, October.
- Ronald L Oaxaca, 1971. "Male-Female Wage Differentials in Urban Labor Markets," Working Papers 396, Princeton University, Department of Economics, Industrial Relations Section..
- Gary S. Becker & Tomas J. Philipson & Rodrigo R. Soares, 2005.
"The Quantity and Quality of Life and the Evolution of World Inequality,"
American Economic Review, American Economic Association, vol. 95(1), pages 277-291, March.
- Gary S. Becker & Tomas J. Philipson & Rodrigo R. Soares, 2003. "The Quantity and Quality of Life and the Evolution of World Inequality," NBER Working Papers 9765, National Bureau of Economic Research, Inc.
- Becker, Gary S., 2004. "The Quantity and Quality of Life and the Evolution of World Inequality," Working Papers 192, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
- Gaynor, Martin & Vogt, William B, 2003.
"Competition among Hospitals,"
RAND Journal of Economics, The RAND Corporation, vol. 34(4), pages 764-785, Winter.
- Martin Gaynor & William Vogt, 2002. "Competition Among Hospitals," GSIA Working Papers 2003-E20, Carnegie Mellon University, Tepper School of Business.
- Martin Gaynor & William B. Vogt, 2003. "Competition Among Hospitals," NBER Working Papers 9471, National Bureau of Economic Research, Inc.
- Martin Gaynor & William B Vogt, 2003. "Competition among Hospitals," The Centre for Market and Public Organisation 03/087, The Centre for Market and Public Organisation, University of Bristol, UK.
- Alan S. Blinder, 1973. "Wage Discrimination: Reduced Form and Structural Estimates," Journal of Human Resources, University of Wisconsin Press, vol. 8(4), pages 436-455.
- Sun Eric & Jena Anupam B & Lakdawalla Darius & Reyes Carolina & Philipson Tomas J & Goldman Dana, 2010. "The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000," Forum for Health Economics & Policy, De Gruyter, vol. 13(2), pages 1-22, February.
- Robert E. Hall & Charles I. Jones, 2007.
"The Value of Life and the Rise in Health Spending,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 122(1), pages 39-72.
- Robert E. Hall & Charles I. Jones, 2005. "The value of life and the rise in health spending," Proceedings, Federal Reserve Bank of San Francisco.
- Robert E. Hall & Charles I. Jones, 2004. "The Value of Life and the Rise in Health Spending," NBER Working Papers 10737, National Bureau of Economic Research, Inc.
- Kevin M. Murphy & Robert H. Topel, 2006.
"The Value of Health and Longevity,"
Journal of Political Economy, University of Chicago Press, vol. 114(5), pages 871-904, October.
- Kevin M. Murphy & Robert H. Topel, 2005. "The Value of Health and Longevity," NBER Working Papers 11405, National Bureau of Economic Research, Inc.
- David M. Cutler & Elizabeth Richardson, 1997. "Measuring the Health of the U.S. Population," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 28(1997 Micr), pages 217-282.
- Bo E. Honoré & Adriana Lleras-Muney, 2006.
"Bounds in Competing Risks Models and the War on Cancer,"
Econometrica, Econometric Society, vol. 74(6), pages 1675-1698, November.
- Bo E. Honoré & Adriana Lleras-Muney, 2004. "Bounds in Competing Risks Models and the War on Cancer," CAM Working Papers 2004-08, University of Copenhagen. Department of Economics. Centre for Applied Microeconometrics.
- Bo E. Honore & Adriana Lleras Muney, 2004. "Bounds in Competing Risks Models and the War on Cancer," NBER Working Papers 10963, National Bureau of Economic Research, Inc.
- Ernst R. Berndt & Iain M. Cockburn & Zvi Griliches, 1996.
"Pharmaceutical Innovations and Market Dynamics: Tracking Effects on Price Indexes for Antidepressant Drugs,"
Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 27(1996 Micr), pages 133-199.
- Ernst R. Berndt & Iain M. Cockburn & Zvi Griliches, 1996. "Pharmaceutical Innovations and Market Dynamics: Tracking Effects on Price Indexes for Antidepressant Drugs," Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution, vol. 27(1996 Micr), pages 201-267.
- Grabowski, Henry G & Vernon, John M, 1992. "Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act," Journal of Law and Economics, University of Chicago Press, vol. 35(2), pages 331-350, October.
- Nancy Devlin & David Parkin, 2004. "Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis," Health Economics, John Wiley & Sons, Ltd., vol. 13(5), pages 437-452, May.
- Gary Becker & Kevin Murphy & Tomas Philipson, 2007.
"The Value of Life Near its End and Terminal Care,"
Levine's Working Paper Archive
122247000000001428, David K. Levine.
- Gary Becker & Kevin Murphy & Tomas Philipson, 2007. "The Value of Life Near its End and Terminal Care," NBER Working Papers 13333, National Bureau of Economic Research, Inc.
- DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G., 2003. "The price of innovation: new estimates of drug development costs," Journal of Health Economics, Elsevier, vol. 22(2), pages 151-185, March.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Frank R. Lichtenberg, 2014.
"Has Medical Innovation Reduced Cancer Mortality?,"
CESifo Economic Studies, CESifo Group, vol. 60(1), pages 135-177.
- Frank R. Lichtenberg, 2010. "Has medical innovation reduced cancer mortality?," NBER Working Papers 15880, National Bureau of Economic Research, Inc.
- Kyle, Margaret & Dubois, Pierre, 2016. "The Effects of Pharmaceutical Innovation on Cancer Mortality," CEPR Discussion Papers 11487, C.E.P.R. Discussion Papers.
- Tomas J. Philipson & Sachin Kamal-Bahl & Anupam B. Jena, 2017. "Defining Value: The Need for a Longer, Broader View," PharmacoEconomics, Springer, vol. 35(7), pages 669-672, July.
- Rheinberger, Christoph M. & Herrera-Araujo, Daniel & Hammitt, James K., 2016.
"The value of disease prevention vs treatment,"
Journal of Health Economics, Elsevier, vol. 50(C), pages 247-255.
- Christoph M Rheinberger & Daniel Herrera-Araujo & James K. Hammitt, 2016. "The value of disease prevention vs treatment," PSE-Ecole d'économie de Paris (Postprint) halshs-01626801, HAL.
- Christoph M Rheinberger & Daniel Herrera-Araujo & James K. Hammitt, 2016. "The value of disease prevention vs treatment," Post-Print halshs-01626801, HAL.
- Rodrigo Camejo & Clare McGrath & Marisa Miraldo & Frans Rutten, 2014. "Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(4), pages 439-445, May.
- Bloom, David E. & Chen, Simiao & Kuhn, Michael & McGovern, Mark E. & Oxley, Les & Prettner, Klaus, 2020.
"The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea,"
The Journal of the Economics of Ageing, Elsevier, vol. 17(C).
- Bloom, David E. & Chen, Simiao & Kuhn, Michael & McGovern, Mark & Oxley, Les T. & Prettner, Klaus, 2017. "The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea," Hohenheim Discussion Papers in Business, Economics and Social Sciences 09-2017, University of Hohenheim, Faculty of Business, Economics and Social Sciences.
- David E. Bloom & Simiao Chen & Michael Kuhn & Mark E. McGovern & Les Oxley & Klaus Prettner, 2017. "The Economic Burden of Chronic Diseases: Estimates and Projections for China, Japan, and South Korea," NBER Working Papers 23601, National Bureau of Economic Research, Inc.
- Bloom, David E. & Chen, Simiao & Kuhn, Michael & McGovern, Mark E. & Oxley, Les & Prettner, Klaus, 2017. "The Economic Burden of Chronic Diseases: Estimates and Projections for China, Japan and South Korea," IZA Discussion Papers 10896, Institute of Labor Economics (IZA).
- Kyle R. Myers, 2022. "Some Tradeoffs of Competition in Grant Contests," Papers 2207.02379, arXiv.org, revised Mar 2024.
- Amitabh Chandra & Jonathan S. Skinner, 2011. "Technology Growth and Expenditure Growth in Health Care," NBER Working Papers 16953, National Bureau of Economic Research, Inc.
- Hammitt, James K. & Herrera-Araujo, Daniel & Rheinberger, Christoph, 2016. "The Value of Cancer Prevention vs Treatment," TSE Working Papers 16-628, Toulouse School of Economics (TSE).
- Shafrin, Jason & Skornicki, Michelle & Brauer, Michelle & Villeneuve, Julie & Lees, Michael & Hertel, Nadine & Penrod, John R. & Jansen, Jeroen, 2018. "An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?," Health Policy, Elsevier, vol. 122(6), pages 607-613.
- Rebecca M. Myerson & Reginald D. Tucker‐Seeley & Dana P. Goldman & Darius N. Lakdawalla, 2020.
"Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?,"
Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 39(3), pages 577-604, June.
- Rebecca Myerson & Reginald Tucker-Seeley & Dana Goldman & Darius Lakdawalla, 2019. "Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?," Working Papers 2019-054, Human Capital and Economic Opportunity Working Group.
- Rebecca Mary Myerson & Reginald Tucker-Seeley & Dana Goldman & Darius N. Lakdawalla, 2019. "Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?," NBER Working Papers 26292, National Bureau of Economic Research, Inc.
- Adam Leive & Thomas Stratmann, 2015. "Do national cancer screening guidelines reduce mortality?," Journal of Population Economics, Springer;European Society for Population Economics, vol. 28(4), pages 1075-1095, October.
- Laura Grigolon & Laura Lasio, 2023. "Biased Beliefs and Stigma as Barriers to Treatment and Innovation Adoption," CRC TR 224 Discussion Paper Series crctr224_2023_277v2, University of Bonn and University of Mannheim, Germany.
- Amitabh Chandra, 2011. "Comment on "The Value of Progress against Cancer in the Elderly"," NBER Chapters, in: Investigations in the Economics of Aging, pages 233-236, National Bureau of Economic Research, Inc.
- Eric Budish & Benjamin N. Roin & Heidi Williams, 2015.
"Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials,"
American Economic Review, American Economic Association, vol. 105(7), pages 2044-2085, July.
- Eric Budish & Benjamin N. Roin & Heidi Williams, 2013. "Do firms underinvest in long-term research? Evidence from cancer clinical trials," NBER Working Papers 19430, National Bureau of Economic Research, Inc.
- Eric Budish & Benjamin Roin & Heidi Williams, 2013. "Do fixed patent terms distort innovation? Evidence from cancer clinical trials," Discussion Papers 13-001, Stanford Institute for Economic Policy Research.
- Dubois, Pierre & Kyle, Margaret, 2016. "The Effects of Pharmaceutical Innovation on Cancer Mortality Rates," TSE Working Papers 16-688, Toulouse School of Economics (TSE).
- Hintermann, Beat & Minke, Matthias, 2018. "The value of extending life at its end: Health care allocation in the presence of learning spillovers," Working papers 2018/15, Faculty of Business and Economics - University of Basel.
- Engy Ziedan & Kosali I. Simon & Coady Wing, 2022. "Mortality Effects of Healthcare Supply Shocks: Evidence Using Linked Deaths and Electronic Health Records," NBER Working Papers 30553, National Bureau of Economic Research, Inc.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Amitabh Chandra & Jonathan S. Skinner, 2011. "Technology Growth and Expenditure Growth in Health Care," NBER Working Papers 16953, National Bureau of Economic Research, Inc.
- Tomas J. Philipson & Eric Sun, 2008.
"Is the Food And Drug Administration Safe And Effective?,"
Journal of Economic Perspectives, American Economic Association, vol. 22(1), pages 85-102, Winter.
- Tomas J. Philipson & Eric Sun, 2007. "Is the Food and Drug Administration Safe and Effective?," NBER Working Papers 13561, National Bureau of Economic Research, Inc.
- Philipson, Tomas J. & Sun, Eric, 2007. "Is the Food and Drug Administration Safe and Effective?," Working Papers 218, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
- Philipson Tomas J. & Sun Eric & Goldman Dana & Jena Anupam B., 2012. "A Reexamination of the Costs of Medical R&D Regulation," Forum for Health Economics & Policy, De Gruyter, vol. 15(1), pages 1-28, October.
- Cameron, Trudy Ann & DeShazo, J.R., 2013. "Demand for health risk reductions," Journal of Environmental Economics and Management, Elsevier, vol. 65(1), pages 87-109.
- Ryan Edwards, 2013.
"The cost of uncertain life span,"
Journal of Population Economics, Springer;European Society for Population Economics, vol. 26(4), pages 1485-1522, October.
- Ryan D. Edwards, 2008. "The Cost of Uncertain Life Span," NBER Working Papers 14093, National Bureau of Economic Research, Inc.
- Kai Hong & Peter A. Savelyev & Kegon T. K. Tan, 2020.
"Understanding the Mechanisms Linking College Education with Longevity,"
Journal of Human Capital, University of Chicago Press, vol. 14(3), pages 371-400.
- Hong, Kai & Savelyev, Peter A. & Tan, Kegon T.K., 2020. "Understanding the Mechanisms Linking College Education with Longevity," IZA Discussion Papers 13118, Institute of Labor Economics (IZA).
- Kai Hong & Peter Savelyev & Kegon Teng Kok Tan, 2020. "Understanding the Mechanisms Linking College Education with Longevity," Working Papers 2020-022, Human Capital and Economic Opportunity Working Group.
- Eric Budish & Benjamin Roin & Heidi Williams, 2013. "Do fixed patent terms distort innovation? Evidence from cancer clinical trials," Discussion Papers 13-001, Stanford Institute for Economic Policy Research.
- Maik T. Schneider & Ralph Winkler, 2021.
"Growth and Welfare under Endogenous Lifetimes,"
Scandinavian Journal of Economics, Wiley Blackwell, vol. 123(4), pages 1339-1384, October.
- Maik T. Schneider & Ralph Winkler, 2010. "Growth and Welfare under Endogenous Lifetime," Diskussionsschriften dp1013, Universitaet Bern, Departement Volkswirtschaft.
- Maik T. Schneider & Ralph Winkler, 2017. "Growth and Welfare under Endogenous Lifetime," CESifo Working Paper Series 6367, CESifo.
- Schneider, Maik & Winkler, Ralph, 2013. "Growth and Welfare under Endogenous Lifetime," VfS Annual Conference 2013 (Duesseldorf): Competition Policy and Regulation in a Global Economic Order 80018, Verein für Socialpolitik / German Economic Association.
- Maik T. Schneider & Ralph Winkler, 2010. "Growth and Welfare under Endogenous Lifetime," CER-ETH Economics working paper series 10/137, CER-ETH - Center of Economic Research (CER-ETH) at ETH Zurich.
- Juan Carlos Córdoba & Marla Ripoll, 2019.
"The Elasticity of Intergenerational Substitution, Parental Altruism, and Fertility Choice,"
The Review of Economic Studies, Review of Economic Studies Ltd, vol. 86(5), pages 1935-1972.
- Cordoba, Juan Carlos & Ripoll, Marla, 2014. "The Elasticity of Intergenerational Substitution, Parental Altruism, and Fertility Choice," Staff General Research Papers Archive 37766, Iowa State University, Department of Economics.
- Marla Ripoll & Juan Cordoba, 2017. "The Elasticity of Intergenerational Substitution, Parental Altruism, and Fertility Choice," 2017 Meeting Papers 428, Society for Economic Dynamics.
- Cordoba, Juan Carlos & Ripoll, Marla, 2014. "The elasticity of intergenerational substitution, parental altruism, and fertility choice," ISU General Staff Papers 201406010700001025, Iowa State University, Department of Economics.
- Marla Ripoll, 2014. "The Elasticity of Intergenerational Substitution, Parental Altruism, and Fertility Choice," Working Paper 5658, Department of Economics, University of Pittsburgh.
- Marla Ripoll, 2018. "The Elasticity of Intergenerational Substitution, Parental Altruism, and Fertility Choice," Working Paper 6397, Department of Economics, University of Pittsburgh.
- Cordoba, Juan Carlos & Ripoll, Marla, 2014. "The Elasticity of Intergenerational Substitution, Parental Altruism, and Fertility Choice," Staff General Research Papers Archive 37765, Iowa State University, Department of Economics.
- St-Amour, Pascal, 2024. "Valuing life over the life cycle," Journal of Health Economics, Elsevier, vol. 93(C).
- Stefan Felder & Andreas Werblow, 2009. "The Marginal Cost of Saving a Life in Health Care: Age, Gender and Regional Differences in Switzerland," Swiss Journal of Economics and Statistics (SJES), Swiss Society of Economics and Statistics (SSES), vol. 145(II), pages 137-153, June.
- Juan Carlos Cordoba, 2015.
"Children, Dynastic Altruism and the Wealth of Nations,"
Review of Economic Dynamics, Elsevier for the Society for Economic Dynamics, vol. 18(4), pages 774-791, October.
- Juan Carlos Cordoba, 2015. "Online Appendix to "Children, Dynastic Altruism and the Wealth of Nations"," Online Appendices 13-127, Review of Economic Dynamics.
- Cordoba, Juan Carlos, 2015. "Children, dynastic altruism and the wealth of nations," ISU General Staff Papers 201501010800001126, Iowa State University, Department of Economics.
- Juan Carlos Cordoba, 2015. "Code and data files for "Children, Dynastic Altruism and the Wealth of Nations"," Computer Codes 13-127, Review of Economic Dynamics.
- Murtin, Fabrice & Boarini, Romina & Cordoba, Juan Carlos & Ripoll, Marla, 2017.
"Beyond GDP: Is there a law of one shadow price?,"
European Economic Review, Elsevier, vol. 100(C), pages 390-411.
- Fabrice Murtin & Romina Boarini & Juan Cordoba & Marla Ripoll, 2015. "Beyond GDP: Is there a law of one shadow price?," OECD Statistics Working Papers 2015/5, OECD Publishing.
- Romina Boarini & Marla Ripoll & Juan Cordoba & Fabrice Murtin, 2016. "Beyond GDP: Is There a Law of One Shadow Price?," 2016 Meeting Papers 527, Society for Economic Dynamics.
- Mr. Kenichi Ueda, 2008. "Life Expectancy and Income Convergence in the World: A Dynamic General Equilibrium Analysis," IMF Working Papers 2008/158, International Monetary Fund.
- Romina Boarini & Marc Fleurbaey & Fabrice Murtin & Paul Schreyer, 2022.
"Well‐being during the Great Recession: new evidence from a measure of multi‐dimensional living standards with heterogeneous preferences,"
Scandinavian Journal of Economics, Wiley Blackwell, vol. 124(1), pages 104-138, January.
- Romina Boarini & Marc Fleurbaey & Fabrice Murtin & Paul Schreyer, 2022. "Well‐being during the Great Recession: new evidence from a measure of multi‐dimensional living standards with heterogeneous preferences," PSE-Ecole d'économie de Paris (Postprint) halshs-03907676, HAL.
- Romina Boarini & Marc Fleurbaey & Fabrice Murtin & Paul Schreyer, 2022. "Well‐being during the Great Recession: new evidence from a measure of multi‐dimensional living standards with heterogeneous preferences," Post-Print halshs-03907676, HAL.
- Felder, Stefan & Werblow, Andreas & Zweifel, Peter, 2010. "Do red herrings swim in circles? Controlling for the endogeneity of time to death," Journal of Health Economics, Elsevier, vol. 29(2), pages 205-212, March.
- Cordoba, Juan Carlos & Ripoll, Marla, 2012.
"Life, Death and World Inequality,"
Staff General Research Papers Archive
34945, Iowa State University, Department of Economics.
- Juan Cordoba & Marla Ripoll, 2012. "Life, Death and World Inequality," 2012 Meeting Papers 925, Society for Economic Dynamics.
- Cordoba, Juan Carlos & Ripoll, Marla, 2012. "Life, death and world inequality," ISU General Staff Papers 201203010800001066, Iowa State University, Department of Economics.
- Dora L. Costa, 2015.
"Health and the Economy in the United States from 1750 to the Present,"
Journal of Economic Literature, American Economic Association, vol. 53(3), pages 503-570, September.
- Dora Costa, 2013. "Health and the Economy in the United States, from 1750 to the Present," NBER Working Papers 19685, National Bureau of Economic Research, Inc.
- Charles I. Jones, 2016.
"Life and Growth,"
Journal of Political Economy, University of Chicago Press, vol. 124(2), pages 539-578.
- Charles I. Jones, 2011. "Life and Growth," NBER Working Papers 17094, National Bureau of Economic Research, Inc.
- Filson, Darren & Oweis, Ahmed, 2010. "The impacts of the rise of Paragraph IV challenges on startup alliance formation and firm value in the pharmaceutical industry," Journal of Health Economics, Elsevier, vol. 29(4), pages 575-584, July.
More about this item
Keywords
Cancer Economic gains Life expectancy;JEL classification:
- I1 - Health, Education, and Welfare - - Health
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
- I28 - Health, Education, and Welfare - - Education - - - Government Policy
- I31 - Health, Education, and Welfare - - Welfare, Well-Being, and Poverty - - - General Welfare, Well-Being
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:jhecon:v:29:y:2010:i:3:p:333-346. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/inca/505560 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.